H

Hacettepe University Hospital | Hematology Department

Research site

(Unclaimed)

Location

Hacettepe Mh. 06230, Ankara, Ankara, Turkey

Site insights

Top conditions

Top treatments

JNJ-73763989

Guselkumab

JNJ-56136379

Interferon

JNJ-81201887

FP-045

Parent organization

This site is a part of Hacettepe University Hospital

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 18 total trials

A Dose Escalation Study of FP-045 in Patients With Fanconi Anemia

This is a multi-center, Phase 1/2 study to determine the Optimal Biologic Dose (OBD) and to evaluate the safety, tolerability, PK, and preliminary ac...

Enrolling

Fanconi Anemia

Drug: FP-045

A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis (QUASAR)

The purpose of this study is to evaluate the efficacy and safety of guselkumab in participants with moderately to severely active ulcerative colitis...

Active, not recruiting

Ulcerative Colitis

Drug: Guselkumab

Drug: Placebo

A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease (GRAVITI)

The purpose of this study is to evaluate the efficacy and safety of guselkumab in participants with Crohn's disease.

Active, not recruiting

Crohn Disease

Drug: Guselkumab Dose 3

Drug: Placebo

A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus (REEF-D)

The purpose of the study is to evaluate on-treatment efficacy against hepatitis D virus (HDV) of JNJ-73763989 + nucleos(t)ide analog (NA) regimen com...

Active, not recruiting

Hepatitis D, Chronic

Drug: Placebo

Drug: JNJ-73763989